Healthcare  Contact Us


There are many challenges facing healthcare, from aging populations, rapidly growing demand for health products and services, severe budget pressures and government reform to global health threats that defy conventional approaches. And each challenge requires the most imaginative of minds – people willing to ask big questions, take risks and tackle complex problems in new ways. At FleishmanHillard, we believe...

There are many challenges facing healthcare, from aging populations, rapidly growing demand for health products and services, severe budget pressures and government reform to global health threats that defy conventional approaches. And each challenge requires the most imaginative of minds – people willing to ask big questions, take risks and tackle complex problems in new ways. At FleishmanHillard, we believe there's an answer to every question that can be posed – we just have to be curious, persistent, collaborative and creative enough to find it. So regardless of the task – building brand loyalty, educating the public or defending a marketplace in the face of intense competition – our team provides the curiosity, experience and confidence to push the boundaries of healthcare communications.

What We Do

Reputation Management

Our teams provide a wide spectrum of reputation management consulting services, from support for leadership changes and mergers and acquisitions to employee communications, issues preparedness and crisis response. Equipped with proprietary tools such as our Authenticity Gap methodology, we help organizations across the healthcare sector identify and take positive steps toward managing the gaps between their brand and reputation.

Product Launch and Marketing

Each market and therapeutic category provides its own challenges, opportunities and circle of stakeholders. From clinical trial recruitment to end-of-lifecycle strategies, FleishmanHillard provides insights into the introduction and marketing of new and mature products. With a deep understanding of the regulatory environments and market complexities in which they work, our counselors have helped create powerful campaigns to launch products at a global, regional and national level – shaping a positive environment for product uptake and generating ongoing demand.

Clinical Trial Recruitment

FleishmanHillard provides specialized patient recruitment consulting for investigational pharmaceutical, biotechnology and medical device products. Working collaboratively with contract research organizations and our clients, we engage target populations through credible third-party sources – online and off – helping study sites raise awareness, educate and generate referrals.

John McAnulty

John McAnulty

Public Affairs and Government Relations

FleishmanHillard provides an in-depth understanding of local, regional and global healthcare issues, advocacy, alliance development, stakeholder engagement and government affairs. We help healthcare companies, trade associations and nongovernmental organizations navigate regulation, mobilize opinion leaders, and influence legislation and health policy. Our healthcare-focused public affairs experts around the world have extensive experience counseling organizations on the wide range of product, corporate and marketplace issues.

Digital and Social Outreach

FleishmanHillard’s digital and social experts worldwide help organizations apply new technologies, tools and channels to shape integrated communications programs that create a measurable impact. We work with clients to optimize the power of social media, including implementing policies for employees, launching branded promotional and unbranded educational campaigns, working with HR to enhance recruitment and retention, and coaching executives in the medium.


Animal healthcare
Health NGOs
Healthcare technology providers
Managed care and insurance providers
Medical equipment and device makers
Medical facilities and providers

Who We Are

  • The Affordable Care Act Turns 5

    Erin Seidler

    March 27, 2015

    Erin Seidler This week marks the 5th anniversary of the passage of the Affordable Care Act. While the law appears to be making progress toward achieving its goals, it remains as divisive as ever and continues to face attempts to dismantle the law. Just last month, emboldened by the new Republican majority in the U.S. Senate, the...

  • The New, New Healthcare Law

    Richard Sorian

    March 27, 2015

    Richard Sorian Like the homeowner who winds up tripling his remodeling budget by telling the contractor “While you’re at it, can you ..." Congress is wrapping up what might be the most significant healthcare bill since the Affordable Care Act of 2010. What started out as a bill to fix a broken Medicare payment system for doctors...

  • Good News for Doctors and Children!

    Richard Sorian

    March 19, 2015

    Richard Sorian Congress is poised to do something remarkable. Republicans and Democrats in the House and Senate are ready to enact legislation putting an end to an 18-year odyssey that alienated millions of physicians and created a continual environment of uncertainty for both practitioners and a vulnerable patient population. At the same time, they plan to extend...

  • Does the Affordable Care Act Have Nine Lives?

    Richard Sorian

    March 5, 2015

    Richard Sorian Today’s oral arguments before the U.S. Supreme Court are just the latest challenge to the Affordable Care Act (ACA), the sweeping healthcare reform law enacted in 2010 also known as “Obamacare”. And it is not likely it will be the last. This isn’t the first time the pundits declared the ACA DOA: In 2009, the...

  • Changes Afoot for Vaccine Production in Russia

    Marina Yarovikova

    February 3, 2015

    Marina Yarovikova The Russian Ministry of Health plans to bring all Russian vaccine producers into a single national immune-biological cluster in 2015. In Russia, the market for the vaccines included in the National Immunization Schedule is quite a special segment of the pharmaceutical market. The main buyer of prophylactic vaccines is the State, which is also the...

  • It’s the Most Wonderful Time of Year

    Adam Silverstein

    January 16, 2015

    Adam Silverstein It’s the most wonderful time of year. For healthcare, that is. This week in San Francisco, over 300 healthcare companies, both public and private, presented vision, business objectives, challenges and opportunities for 2015 at arguably the year’s largest meeting, the 33rd Annual J.P. Morgan (client) Healthcare Conference. Investors, media, healthcare professionals, even patient advocates swarmed...

  • Taking the Pulse: Obamacare Round Two

    Richard Sorian

    November 11, 2014

    Richard Sorian Hard to believe it’s time for the second year of full implementation of the Affordable Care Act —aka Obamacare. On November 15, the health insurance marketplaces reopen for business for Americans to shop for private health insurance. Proponents are hoping this year will look nothing like last year’s debacle. The Obama Administration, worried about setting...

  • Taking the Pulse: What Will the New Congress Prescribe on Healthcare Policy?

    Richard Sorian

    November 6, 2014

    Richard Sorian Now that the 2014 elections are more or less over (ah, runoffs…) it’s time to consider their impact. Republicans made strong gains in both houses of Congress, cementing their already strong majority in the House and retaking control of  the Senate in resounding fashion.  Republicans also made gains at the state level and held off...

  • Putting Ebola Into Context

    Pippa Galbraith

    October 17, 2014

    Pippa Galbraith Striking a delicate balance between communicating a healthcare threat and managing public perceptions “Rumours and panic are spreading faster than the virus,” said Dr Margaret Chan, director general of the World Health Organisation on Monday this week. In the same speech she called the Ebola outbreak “a crisis for international peace and security”. While the...

  • Lots Left Unanswered After FDA Social Guidance

    Mark Senak

    July 15, 2014

    Mark Senak For almost five years, the pharmaceutical industry has essentially held its collective breath waiting for guidelines from the U.S. Food and Drug Administration on how it should operate on social media and the Internet. Out of a public hearing held in 2009 with pharmaceutical companies and medical device makers, five pressing questions were posed by...

  • No Roar From Pharma at Cannes Lions Health

    Jenyne Engelhardt

    June 15, 2014

    Jenyne Engelhardt And the Grand Prix winner is…Well, turns out we’re going to have to wait until next year at least in the pharmaceutical category. The pharma jury at the inaugural Cannes Lions Health festival shocked the audience at the Palais des Festivals by opting not to award one, throwing down a challenge to clients and agencies...

  • Saving Lives Is a Creative Endeavour

    Orla Burke

    June 15, 2014

    Orla Burke What if mobile phones could detect cancer cells? Or an ultrasound was performed via television? How would these disruptive technologies impact healthcare models and how would communications adapt to help save lives? These were amongst some of the most provocative questions asked on day one at Lions Health. During a session entitled Creative Ideas and Innovators...

  • It's Pharma's Turn for a Little Sunshine — Get Sunscreen

    Mark Senak

    June 12, 2014

    Mark Senak Last April, as the Centers for Medicare & Medicaid (CMS) released information about individual physician payments from Medicare, there was a firestorm of media about the big bucks some doctors and medical specialties were raking in from the federal program. National and locals outlets piled on, some even posting multiple articles, and naming names of...

  • Curiosity, Creativity and Healthcare

    Anne de Schweinitz

    June 12, 2014

    Anne de Schweinitz Some might think that those of us who work in healthcare lack the creative instinct, that our analytical minds and the rules restricting marketing and communications in the industry squeeze out any room for real originality and inspiration. I disagree completely. When I was a kid my favorite topic in school was biology. I was...